Katerina Kypreou
Overview
Explore the profile of Katerina Kypreou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Association of MC1R variants with melanoma risk and interaction with sun exposure: An M-SKIP project
Stefanaki I, DEcclesiis O, Vignati S, Gaeta A, Kypreou K, Caini S, et al.
J Eur Acad Dermatol Venereol
. 2024 Oct;
PMID: 39425518
No abstract available.
2.
Dessinioti C, Plaka M, Befon A, Polidorou D, Stefanaki I, Kypreou K, et al.
Dermatology
. 2024 Jan;
240(3):462-467.
PMID: 38290473
Introduction: A diameter larger than 6 mm is included in the criteria used in public health messages to detect a cutaneous melanoma. We aimed to investigate the independent association of...
3.
Dessinioti C, Plaka M, Kypreou K, Stergiopoulou A, Kostaki M, Soura E, et al.
J Am Acad Dermatol
. 2023 Feb;
89(1):152-154.
PMID: 36822351
No abstract available.
4.
Kontogianni G, Voutetakis K, Piroti G, Kypreou K, Stefanaki I, Vlachavas E, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765773
Cutaneous melanoma (CM) is the most aggressive type of skin cancer, and it is characterised by high mutational load and heterogeneity. In this study, we aimed to analyse the genomic...
5.
Kostaki M, Plaka M, Moustaki M, Befon A, Champsas G, Kypreou K, et al.
J Eur Acad Dermatol Venereol
. 2022 Oct;
37(5):941-944.
PMID: 36310344
Background: About 2%-20% of melanoma patients will develop cutaneous melanoma metastases (CMM). Their clinical diagnosis still remains challenging because of the variation of clinical and dermoscopic characteristics. Until today, few...
6.
Dessinioti C, Sypsa V, Kypreou K, Dimisianos G, Kodela E, Nikolaou V, et al.
Exp Dermatol
. 2015 Mar;
24(6):476-8.
PMID: 25809071
Melanocortin 1 receptor (MC1R) gene variants are a major contributor to pigmentation characteristics and the modulation of sporadic basal cell carcinoma (BCC) risk. This is a hospital-based, case-control study to...
7.
Athanasiadis E, Antonopoulou K, Chatzinasiou F, Lill C, Bourdakou M, Sakellariou A, et al.
Database (Oxford)
. 2014 Nov;
2014.
PMID: 25380778
The publicly available online database MelGene provides a comprehensive, regularly updated, collection of data from genetic association studies in cutaneous melanoma (CM), including random-effects meta-analysis results of all eligible polymorphisms....
8.
Chatzinasiou F, Lill C, Kypreou K, Stefanaki I, Nicolaou V, Spyrou G, et al.
J Natl Cancer Inst
. 2011 Jun;
103(16):1227-35.
PMID: 21693730
Background: Although genetic studies have reported a number of loci associated with cutaneous melanoma (CM) risk, a comprehensive synopsis of genetic association studies published in the field and systematic meta-analysis...
9.
Dessinioti C, Tzannis K, Sypsa V, Nikolaou V, Kypreou K, Antoniou C, et al.
Exp Dermatol
. 2011 Apr;
20(8):622-6.
PMID: 21521370
Background: Basal cell carcinoma (BCC) is the most common form of skin cancer with increasing incidence rates worldwide. Methods: To assess the association of BCC with epidemiologic risk factors in...
10.
Alberti A, Karamessinis P, Peroulis M, Kypreou K, Kavvadas P, Pagakis S, et al.
Am J Physiol Endocrinol Metab
. 2009 Jul;
297(3):E812-21.
PMID: 19622788
Our studies focus on ERp46, an endoplasmic reticulum (ER) component, and analyze its involvement in glucose toxicity and in insulin production. Differences in pancreatic beta-TC-6 cell proteome under conditions of...